Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma

por Passalidou, E, Stewart, M, Trivella, M, Steers, G, Pillai, G, Dogan, A, Leigh, I, Hatton, C, Harris, A, Gatter, K, Pezzella, F
Publicado 2003

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer

por Kato, T, Steers, G, Campo, L, Roberts, H, Leek, R D, Turley, H, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Harris, A L, Gatter, K C, Pezzella, F
Publicado 2007

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity

por Kato, T, Prevo, R, Steers, G, Roberts, H, Leek, R D, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Jackson, D G, Harris, A L, Gatter, K C, Pezzella, F
Publicado 2005

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding

por Adam, P J, Terrett, J A, Steers, G, Stockwin, L, Loader, J A, Fletcher, G C, Lu, L-S, Leach, B I, Mason, S, Stamps, A C, Boyd, R S, Pezzella, F, Gatter, K C, Harris, A L
Publicado 2006

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer

por da Motta, L L, Ledaki, I, Purshouse, K, Haider, S, De Bastiani, M A, Baban, D, Morotti, M, Steers, G, Wigfield, S, Bridges, E, Li, J-L, Knapp, S, Ebner, D, Klamt, F, Harris, A L, McIntyre, A
Publicado 2017

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer

por Jubb, A M, Turley, H, Moeller, H C, Steers, G, Han, C, Li, J-L, Leek, R, Tan, E Y, Singh, B, Mortensen, N J, Noguera-Troise, I, Pezzella, F, Gatter, K C, Thurston, G, Fox, S B, Harris, A L
Publicado 2009